CAICaris Life SciencesHealth Care
$16.72EarningsAug 11, 2026
1D—1W—1M—3M—1Y—
Market cap$4.7BCompany infoRevenue$907.3M52-wk range$15 – $39IndustryBiotechnologyWebsitecarislifesciences.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −39.6% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S5.2×2633
6
56
P / FCF38.3×2017
EV / EBITDA37.3×108
P / E (fwd)130.7×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin68.7%8165
43%
69%
Operating margin15.9%5153
-13%
61%
Net margin3.8%2433
-73%
42%
ROE———
ROIC23.1%8989
-6%
23%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009590
0.0
3.2
Net debt / EBITDA-7.9×9798
Current ratio7.059597
Interest coverage2.5×2622
Per shareTTM, with year-over-year change
Revenue / share$3.21▲ +125%
EPS (diluted)$-1.51▼ −192%
FCF / share$0.44▲ +120%
Est. EPS growth (fwd)+160%